FDA Inspection
CSL Plasma Inc.CSL Plasma Inc. – FDA Inspection, Jan 9, 2014
Record Details
This FDA Inspection record concerns CSL Plasma Inc., with an inspection on January 9, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CSL Plasma Inc.
- Inspection Date
- January 9, 2014
- Product Type
- Biologics
View Company Profile
ID · 8ccd51cd-ceb5-4353-96f5-38f42944d477
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 861630
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.40(a)(1)Provide space for examination
- 21 CFR 606.160(a)(1)Person performing, test results, interpretation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CSL Plasma Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| December 1, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 14, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 17, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 3, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 23, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for CSL Plasma Inc.
- FDA Inspection 1192853 - 2022-12-01
- FDA Inspection 1032405 - 2017-11-14
- FDA Inspection 925402 - 2015-04-17
- FDA Inspection 770772 - 2012-02-03
- FDA Inspection 671360 - 2010-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.